Last Name First Name Research/Clinical Interest Title Keywords   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROBERSON ERIK Neurobiology of Alzheimer's Disease and Frontotemporal Dementia Neurodegeneration, Alzheimer's disease, frontotemporal dementia, tau, progranulin, excitability, signaling, plasticity, behavior   ROGERS JACK   ROWE GLENN Exercise-Induced Metabolic Adaptations in Striated Muscle striated muscle, mitochondria, transcriptional regulation, metabolism, exercise   ROWE GLENN Exercise-Induced Metabolic Adaptations in Striated Muscle striated muscle, mitochondria, transcriptional regulation, metabolism, exercise   ROWE GLENN Exercise-Induced Metabolic Adaptations in Striated Muscle striated muscle, mitochondria, transcriptional regulation, metabolism, exercise   ROWE STEVEN Cystic Fibrosis Clinical and Translational Research cystic fibrosis, CFTR, nonsense mutations   ROWE STEVEN Cystic Fibrosis Clinical and Translational Research cystic fibrosis, CFTR, nonsense mutations   ROWE STEVEN Cystic Fibrosis Clinical and Translational Research cystic fibrosis, CFTR, nonsense mutations   ROWE STEVEN Cystic Fibrosis Clinical and Translational Research cystic fibrosis, CFTR, nonsense mutations   ROWE STEVEN Cystic Fibrosis Clinical and Translational Research cystic fibrosis, CFTR, nonsense mutations   RUPPERT SUSAN Role of transcription factor oncogenes in tumor initiation.   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   RYAN THOMAS Stem Cell Therapies in Animal Models of Human Disease Sickle cell anemia, thalassemia, embryonic stem cells, hemoglobin, mutagenesis, gene regulation   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SAAD JAMIL HIV-Host Interactions and Fas-Mediated Apoptosis HIV, NMR, Cancer, Drug design   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERS PAUL Mechanisms of Disease Progression in the Kidney salt-sensitive hypertension, transforming growth factor-ß, nitric oxide, hypertensive nephrosclerosis, monoclonal immunoglobulin light-chain-related renal diseases   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance   SANDERSON RALPH Molecular Regulation of the Tumor Microenvironment tumor, microenvironment, cancer, heparan sulfate, proteoglycan, heparanase, exosomes, metastasis, bone, myeloma, breast cancer, drug resistance First Prev   31 32 33 34 35 36 37 38 39 40 of  47  Next Last